Epigenetics in breast cancer therapy—New strategies and future nanomedicine perspectives
V Buocikova, I Rios-Mondragon, E Pilalis… - Cancers, 2020 - mdpi.com
Simple Summary Despite advances in cancer treatment, difficult-to-treat tumor subtypes
remain a challenge. New multidisciplinary approaches can help overcome current obstacles …
remain a challenge. New multidisciplinary approaches can help overcome current obstacles …
DNA repair and personalized breast cancer therapy
SX Li, A Sjolund, L Harris… - Environmental and …, 2010 - Wiley Online Library
Personalized cancer therapy is likely to be one of the next big advances in our search for a
cure for cancer. To be able to treat people in an individualized manner, researchers need to …
cure for cancer. To be able to treat people in an individualized manner, researchers need to …
Pharmacogenomics of breast cancer therapy: an update
K Westbrook, V Stearns - Pharmacology & therapeutics, 2013 - Elsevier
Clinical and histopathologic characteristics of breast cancer have long played an important
role in treatment decision-making. Well-recognized prognostic factors include tumor size …
role in treatment decision-making. Well-recognized prognostic factors include tumor size …
Recent advances in the treatment of breast cancer
CWS Tong, M Wu, WCS Cho, KKW To - Frontiers in oncology, 2018 - frontiersin.org
Breast cancer (BC) is the most common malignancy in women. It is classified into a few
major molecular subtypes according to hormone and growth factor receptor expression …
major molecular subtypes according to hormone and growth factor receptor expression …
Deciphering breast cancer: from biology to the clinic
E Nolan, GJ Lindeman, JE Visvader - Cell, 2023 - cell.com
Breast cancer remains a leading cause of cancer-related mortality in women, reflecting
profound disease heterogeneity, metastasis, and therapeutic resistance. Over the last …
profound disease heterogeneity, metastasis, and therapeutic resistance. Over the last …
Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments
U Testa, G Castelli, E Pelosi - Medical Sciences, 2020 - mdpi.com
Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …
million new cases in world in 2018. It is the second leading cause of death from cancer in …
Personalized therapy for breast cancer
FB De Abreu, GN Schwartz, WA Wells… - Clinical …, 2014 - Wiley Online Library
Breast cancer is a complex disease characterized by many morphological, clinical and
molecular features. For many years, this disease has been classified according to …
molecular features. For many years, this disease has been classified according to …
[HTML][HTML] Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters
HG Russnes, OC Lingjærde, AL Børresen-Dale… - The American journal of …, 2017 - Elsevier
Breast carcinomas can be stratified into different entities based on clinical behavior,
histologic features, and/or by biological properties. A classification of breast cancer should …
histologic features, and/or by biological properties. A classification of breast cancer should …
Breast cancer: molecular basis and therapeutic strategies
G Ligresti, M Libra, L Militello… - Molecular …, 2008 - spandidos-publications.com
Breast cancer is the most common malignancy among women. It is frequently treated with
chemotherapy and hormone therapy. More recently, however,'targeted therapy'has emerged …
chemotherapy and hormone therapy. More recently, however,'targeted therapy'has emerged …
Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments
Remarkable progress in sequencing technology over the past 20 years has made it possible
to comprehensively profile tumors and identify clinically relevant genomic alterations. In …
to comprehensively profile tumors and identify clinically relevant genomic alterations. In …